US Stock MarketDetailed Quotes

CSCI COSCIENS Biopharma

Watchlist

4.105
+0.055+1.36%

Trading Sep 11 11:23 ET

12.79MMarket Cap-1528P/E (TTM)

COSCIENS Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

COSCIENS Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2023/Q4	121.000K / 4.000K	--
--	2023/Q3	3.000K / 2.283M	--
--	2023/Q2	2.246M / 1.140M	--
--	2023/Q1	2.128M / 900.000K	--
--	2022/Q4	2.485M / 1.060M	--

DatePeriodRevenue/EstimateEarnings Call

--2023/Q4121.000K / 4.000K--

--2023/Q33.000K / 2.283M--

--2023/Q22.246M / 1.140M--

--2023/Q12.128M / 900.000K--

--2022/Q42.485M / 1.060M--

Unlock Free Earnings Estimates

Open Account

COSCIENS Biopharma Earnings Reports

6-K: Report of foreign private issuer (related to financial reporting)

Aug 13 20:07

6-K: Report of foreign private issuer (related to financial reporting)

Aug 13 20:07

AEterna Zentaris | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

Jul 18 01:18

AEterna Zentaris | 6-K: Report of foreign private issuer (related to financial reporting)

May 17 20:02

Analyst Rating

No Data

Price Target